Serum proteomic patterns for detection of prostate cancer

Journal of the National Cancer Institute

Volumn 94, Issue 20, 2002, Pages 1576-1578

  Petricoin III, Emanuel F ^a,h   Ornstein, David K ^b   Paweletz, Cloud P ^c,d   Ardekani, Ali ^c   Hackett, Paul S ^a   Hitt, Ben A ^e   Velassco, Alfredo ^f   Trucco, Christian ^f   Wiegand, Laura ^a   Wood, Kamillah ^a   Simone, Charles B ^g   Levine, Peter J ^e   Linehan, W Marston ^c   Emmert Buck, Michael R ^c   Steinberg, Seth M ^c   Kohn, Elise C ^c   Liotta, Lance A ^c  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d GEORGETOWN UNIVERSITY   (United States)

^e NIH ^*  (United States)

^f PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^g Simone Protective Cancer Institute   (United States)

^h Simone Protective Cancer Institute ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; PROTEOME;

ADULT; ARTICLE; BIOINFORMATICS; CANCER DIAGNOSIS; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HYPOTHESIS; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; MEDICAL DECISION MAKING; PREDICTION; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; TUMOR BIOPSY;

EID: 0037120949     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/94.20.1576     Document Type: Article

References (8)

1. Paweletz CP, Gillispie JW, Ornstein DK, Simone NL, Brown MR, Cole KA, et al. Rapid protein display profiling of cancer progression directly from human tissue using a protein biochip. Drug Dev Res 2000;49:34-42.
2. Xiao Z, Adam BL, Cazares LH, Clements MA, Davis JW, Schellhammer PF, et al. Quantitation of serum prostate-specific membrane antigen by a novel protein biochip immunoassay discriminates benign from malignant prostate disease. Cancer Res 2001;61: 6029-33.
3. Petricoin EF, Ardekani A, Hitt P, Levine P, Fusaro VA, Steinberg S, et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 2002;359:572-7.
4. Holland JH, editor. Adaptation in natural and artificial systems: an introductory analysis with applications to biology, control, and artificial intelligence. 3rd ed. Cambridge (MA): MIT Press; 1992.
5. Kohonen T. Self-organized formation of topologically correct feature maps. Biol Cybern 1982;43:59-69.
6. Breslow NE, Day NE. Statistical methods in cancer research. Volume I - The analysis of case-control studies. IARC Sci Publ 1980; (32):5-338.
7. Arcangeli CG, Ornstein DK, Keetch DW, Andriole GL. Prostate-specific antigen as a screening test for prostate cancer. The United States experience. Urol Clin North Am 1997; 24:299-306.
8. Keeteli DW, Catalona WJ, Smith DS. Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values. J Urol 1994;151:1571-4.